Tesamorelin is a synthetic hormone-releasing peptide used mainly to reduce excess visceral fat in adults with HIV-associated lipodystrophy. It works by stimulating growth hormone release, which can lower abdominal fat, though it is not a general weight-loss drug.

What it’s used for

  • FDA-approved use: reducing visceral adiposity in people with HIV-related lipodystrophy.
  • Main effect: targets deep belly fat rather than overall body weight.
  • Mechanism: a growth hormone-releasing hormone analogue, so it influences the GH/IGF-1 axis.

What people talk about online

Recent peptide coverage often discusses tesamorelin in the context of anti- aging, body composition, and “performance” use, but those uses are not the standard approved medical indication. Public discussions also tend to blur the line between clinical treatment and gray-market “research use” products, which raises safety concerns.

Safety note

Tesamorelin can affect glucose and lipid metabolism, so it should be used under medical supervision rather than as a casual fitness or fat-loss peptide. The strongest evidence-backed use is still the HIV-related visceral fat indication.

TL;DR: tesamorelin is mainly used to reduce abdominal visceral fat in adults with HIV-associated lipodystrophy, not as a general bodybuilding or anti-aging peptide.